Aoxing Pharma Reports License for Narcotic Cough Treatment
Aoxing Pharma, a China company with a narcotic drugs focus, received an SFDA license to produce the API in pholcodine, an opioid cough suppressant. The company still needs to pass a GMP inspection before it is allowed to market the product. Aoxing owns one of just thirteen narcotics licenses in China. Nevertheless, the company’s revenues for the most recent 12 months were only $9 million, while its loss totaled $15 million. More details.... Stock Symbol: (NYSE MKT: AXN) Share this with colleagues: // //  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here